AMGEN at ASH Annual Meeting

ASH Annual Meeting 2023

December 9-12, 2023 San Diego, California

ADVANCING ALL ANGLES OF CARE

Hematology Clinical Trials

Blinatumomab 014 Study

Clinical Trial Study Card for Blinatumomab 014 Study

A Phase 4, Multi-center Open-label Feasibility Study to Evaluate Outpatient Blinatumomab Administration in Adult Patients With Measurable/Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) in Complete Hematologic Remission.

Dec 09, 2023
Blinatumomab 257 Study

Clinical Trial Study Card for Blinatumomab 257 Study

A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and PK and to Determine the MTD and RP2D of Subcutaneous Blinatumomab Administration for the Treatment of R/R B-ALL.

Nov 10, 2023
Blinatumomab 360 Study

Clinical Trial Study Card for Blinatumomab 360 Study

Phase 3, Randomized, Controlled Study of Blinatumomab Alternating With Low-Intensity Chemotherapy Versus SOC Chemotherapy For Older Adults With Newly Diagnosed Philadelphia-Negative B-Cell Precursor ALL (Golden Gate Study).

Nov 10, 2023
Infographic for Carfilzomib

Clinical Trial Infographic for Carfilzomib

Phase 2 Study of Carfilzomib* in Combination With Induction Chemotherapy in Children With R/R ALL.

Nov 10, 2023
Kyprolis Study Panel

Kyprolis Study Panel

Pediatric trial for relapsed or refractory acute lymphoblastic leukemia.

Nov 10, 2023
AMG 176 Study

Clinical Trial Study Card for the AMG 176 Study

A Phase 1 First-in-Human Study Evaluating the Safety and Tolerability of AMG 176 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia.

Nov 10, 2023
AMG 176 in Combination with Azacitidine

Clinical Trial Study Card for AMG 176 in Combination with Azacitidine

A Phase 1 Study of AMG 176 as Monotherapy and in Combination With Azacitidine in Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.

Nov 10, 2023

*Products under investigational study have not been approved by the regulatory agencies for use under investigation in this trial.

All ANGLES OF CARE

Amgen Oncology is advancing all angles of care.
Through our mission and our medicines, we're transforming what's possible.